IMP4297 in Combination With Temozolomide in Patients With Advanced Solid Tumors and Small Cell Lung Cancer
Clinical trial NCT04434482 · COMPLETED
Trial details
- NCT number
- NCT04434482
- Sponsor
- Impact Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-07
- Primary completion
- 2024-04-29
- Enrollment
- 59
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.